IDXX
Price
$436.91
Change
-$7.81 (-1.76%)
Updated
Dec 11, 04:59 PM (EDT)
61 days until earnings call
XAIR
Price
$0.49
Change
+$0.01 (+2.08%)
Updated
Dec 11, 04:59 PM (EDT)
57 days until earnings call
Ad is loading...

IDXX vs XAIR

Header iconIDXX vs XAIR Comparison
Open Charts IDXX vs XAIRBanner chart's image
IDEXX Laboratories
Price$436.91
Change-$7.81 (-1.76%)
Volume$9.14K
CapitalizationN/A
Beyond Air
Price$0.49
Change+$0.01 (+2.08%)
Volume$12.25K
CapitalizationN/A
IDXX vs XAIR Comparison Chart
Loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XAIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDXX vs. XAIR commentary
Dec 12, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXX is a Buy and XAIR is a Sell.

COMPARISON
Comparison
Dec 12, 2024
Stock price -- (IDXX: $444.72 vs. XAIR: $0.48)
Brand notoriety: IDXX and XAIR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IDXX: 98% vs. XAIR: 89%
Market capitalization -- IDXX: $44.84B vs. XAIR: $79.87M
IDXX [@Medical Specialties] is valued at $44.84B. XAIR’s [@Medical Specialties] market capitalization is $79.87M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDXX’s FA Score shows that 1 FA rating(s) are green whileXAIR’s FA Score has 0 green FA rating(s).

  • IDXX’s FA Score: 1 green, 4 red.
  • XAIR’s FA Score: 0 green, 5 red.
According to our system of comparison, IDXX is a better buy in the long-term than XAIR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDXX’s TA Score shows that 5 TA indicator(s) are bullish while XAIR’s TA Score has 3 bullish TA indicator(s).

  • IDXX’s TA Score: 5 bullish, 4 bearish.
  • XAIR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IDXX is a better buy in the short-term than XAIR.

Price Growth

IDXX (@Medical Specialties) experienced а +2.92% price change this week, while XAIR (@Medical Specialties) price change was -11.46% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.07%. For the same industry, the average monthly price growth was -0.41%, and the average quarterly price growth was +2.41%.

Reported Earning Dates

IDXX is expected to report earnings on Feb 10, 2025.

XAIR is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Medical Specialties (+1.07% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDXX($44.8B) has a higher market cap than XAIR($79.9M). IDXX YTD gains are higher at: -19.877 vs. XAIR (-75.291). IDXX has higher annual earnings (EBITDA): 1.22B vs. XAIR (-67.06M). IDXX has more cash in the bank: 454M vs. XAIR (31.3M). XAIR has less debt than IDXX: XAIR (16.9M) vs IDXX (1.07B). IDXX has higher revenues than XAIR: IDXX (3.66B) vs XAIR (689K).
IDXXXAIRIDXX / XAIR
Capitalization44.8B79.9M56,070%
EBITDA1.22B-67.06M-1,816%
Gain YTD-19.877-75.29126%
P/E Ratio52.87N/A-
Revenue3.66B689K531,350%
Total Cash454M31.3M1,450%
Total Debt1.07B16.9M6,314%
FUNDAMENTALS RATINGS
IDXX vs XAIR: Fundamental Ratings
IDXX
XAIR
OUTLOOK RATING
1..100
1867
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
57100
SMR RATING
1..100
1799
PRICE GROWTH RATING
1..100
6063
P/E GROWTH RATING
1..100
87100
SEASONALITY SCORE
1..100
38n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XAIR's Valuation (34) in the null industry is somewhat better than the same rating for IDXX (85) in the Medical Specialties industry. This means that XAIR’s stock grew somewhat faster than IDXX’s over the last 12 months.

IDXX's Profit vs Risk Rating (57) in the Medical Specialties industry is somewhat better than the same rating for XAIR (100) in the null industry. This means that IDXX’s stock grew somewhat faster than XAIR’s over the last 12 months.

IDXX's SMR Rating (17) in the Medical Specialties industry is significantly better than the same rating for XAIR (99) in the null industry. This means that IDXX’s stock grew significantly faster than XAIR’s over the last 12 months.

IDXX's Price Growth Rating (60) in the Medical Specialties industry is in the same range as XAIR (63) in the null industry. This means that IDXX’s stock grew similarly to XAIR’s over the last 12 months.

IDXX's P/E Growth Rating (87) in the Medical Specialties industry is in the same range as XAIR (100) in the null industry. This means that IDXX’s stock grew similarly to XAIR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDXXXAIR
RSI
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 20 days ago
70%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XAIR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTGR25.080.91
+3.76%
NETGEAR
VVX59.490.67
+1.14%
V2X
YPF40.650.14
+0.35%
YPF Sociedad Anonima
DBVT3.45-0.04
-1.20%
DBV Technologies S.A
MRK101.00-2.79
-2.69%
Merck & Co

IDXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDXX has been loosely correlated with MYGN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IDXX jumps, then MYGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXX
1D Price
Change %
IDXX100%
-1.32%
MYGN - IDXX
48%
Loosely correlated
+3.09%
TMO - IDXX
45%
Loosely correlated
-0.26%
TFX - IDXX
44%
Loosely correlated
-0.28%
SNN - IDXX
43%
Loosely correlated
-0.47%
IQV - IDXX
42%
Loosely correlated
-1.57%
More

XAIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XAIR has been loosely correlated with OPK. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if XAIR jumps, then OPK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XAIR
1D Price
Change %
XAIR100%
-2.97%
OPK - XAIR
35%
Loosely correlated
-1.27%
KIDS - XAIR
32%
Poorly correlated
+2.36%
SHWGY - XAIR
32%
Poorly correlated
N/A
CERS - XAIR
31%
Poorly correlated
+1.12%
IDXX - XAIR
31%
Poorly correlated
-1.32%
More